Virbac   Report issue

For profit Phase 2 Phase 4
Founded: Forth Worth TX United States (1987)
Status: No NME R&D (1987)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Virbac (0) Acquired (1)

ethylenediamine (1 trial)

Drugs in Phase 2 Trials (5)

Key: Virbac (0) Acquired (5)

aluminum (1 trial)

Hydroxymethylpentylcyclohexenecarboxaldehyde (lyral) (1 trial)

mercury (1 trial)

metal allergen (1 trial)

palladium (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 4
  • # of Trial APIs: 6